PET Nuclear Medicine Market Forecast to 2027 - COVID-19 Impact and Global Analysis By : Type ( F-18, Rb-82, Other PET Isotopes ); Applications ( Oncology, Cardiology, Neurology, Other PET Applications )

Report Code: TIPRE00015978 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

PET nuclear medicine procedure is used to determine the metabolic activity of the cells in the body. Positron emission tomography (PET) scan, an imaging test helps in understanding the tissues and organs functioning in the patient. It helps in diagnosing, evaluating and treating a variety of diseases.

MARKET DYNAMICS

The PET nuclear medicine market is driving due to the growing incidence and prevalence of target health conditions, and increasing number of PET procedures. However, short half-life of radiopharmaceuticals may hamper the growth of the global PET nuclear medicine market.

MARKET SCOPE

The "PET nuclear medicine Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of PET nuclear medicine market with detailed market segmentation by type and application. The PET nuclear medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in PET nuclear medicine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The PET nuclear medicine market is segmented on the basis of type and application. Based on type, the market is segmented as F-18, Rb-82, Other PET Isotopes. On the basis of application, the market is categorized as oncology, cardiology, neurology, and other pet applications.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PET nuclear medicine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PET nuclear medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting PET nuclear medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PET nuclear medicine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the PET nuclear medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PET nuclear medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for PET nuclear medicine in the global market. Below mentioned is the list of few companies engaged in the PET nuclear medicine market.

The report also includes the profiles of key players in PET nuclear medicine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Cardinal Health
  •   Curium
  •   GE Healthcare
  •   Lantheus Medical Imaging, Inc.
  •   Bayer AG
  •   Bracco Imaging S.P.A.
  •   Eczacibasi-Monrol Nuclear Products
  •   Nordion, Inc. (A Subsidiary of Sterigenics International)
  •   Advanced Accelerator Applications (AAA) (A Part of Novartis)
  •   NTP Radioisotopes Soc, LTD.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 PET Nuclear Medicine Market - By Type
1.3.2 PET Nuclear Medicine Market - By Applications
1.3.3 PET Nuclear Medicine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PET NUCLEAR MEDICINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PET NUCLEAR MEDICINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PET NUCLEAR MEDICINE MARKET - GLOBAL MARKET ANALYSIS
6.1. PET NUCLEAR MEDICINE - GLOBAL MARKET OVERVIEW
6.2. PET NUCLEAR MEDICINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PET NUCLEAR MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. F-18
7.3.1. Overview
7.3.2. F-18 Market Forecast and Analysis
7.4. RB-82
7.4.1. Overview
7.4.2. Rb-82 Market Forecast and Analysis
7.5. OTHER PET ISOTOPES
7.5.1. Overview
7.5.2. Other PET Isotopes Market Forecast and Analysis
8. PET NUCLEAR MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. CARDIOLOGY
8.4.1. Overview
8.4.2. Cardiology Market Forecast and Analysis
8.5. NEUROLOGY
8.5.1. Overview
8.5.2. Neurology Market Forecast and Analysis
8.6. OTHER PET APPLICATIONS
8.6.1. Overview
8.6.2. Other PET Applications Market Forecast and Analysis
9. PET NUCLEAR MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America PET Nuclear Medicine Market Overview
9.1.2 North America PET Nuclear Medicine Market Forecasts and Analysis
9.1.3 North America PET Nuclear Medicine Market Forecasts and Analysis - By Type
9.1.4 North America PET Nuclear Medicine Market Forecasts and Analysis - By Applications
9.1.5 North America PET Nuclear Medicine Market Forecasts and Analysis - By Countries
9.1.5.1 United States PET Nuclear Medicine Market
9.1.5.1.1 United States PET Nuclear Medicine Market by Type
9.1.5.1.2 United States PET Nuclear Medicine Market by Applications
9.1.5.2 Canada PET Nuclear Medicine Market
9.1.5.2.1 Canada PET Nuclear Medicine Market by Type
9.1.5.2.2 Canada PET Nuclear Medicine Market by Applications
9.1.5.3 Mexico PET Nuclear Medicine Market
9.1.5.3.1 Mexico PET Nuclear Medicine Market by Type
9.1.5.3.2 Mexico PET Nuclear Medicine Market by Applications
9.2. EUROPE
9.2.1 Europe PET Nuclear Medicine Market Overview
9.2.2 Europe PET Nuclear Medicine Market Forecasts and Analysis
9.2.3 Europe PET Nuclear Medicine Market Forecasts and Analysis - By Type
9.2.4 Europe PET Nuclear Medicine Market Forecasts and Analysis - By Applications
9.2.5 Europe PET Nuclear Medicine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany PET Nuclear Medicine Market
9.2.5.1.1 Germany PET Nuclear Medicine Market by Type
9.2.5.1.2 Germany PET Nuclear Medicine Market by Applications
9.2.5.2 France PET Nuclear Medicine Market
9.2.5.2.1 France PET Nuclear Medicine Market by Type
9.2.5.2.2 France PET Nuclear Medicine Market by Applications
9.2.5.3 Italy PET Nuclear Medicine Market
9.2.5.3.1 Italy PET Nuclear Medicine Market by Type
9.2.5.3.2 Italy PET Nuclear Medicine Market by Applications
9.2.5.4 Spain PET Nuclear Medicine Market
9.2.5.4.1 Spain PET Nuclear Medicine Market by Type
9.2.5.4.2 Spain PET Nuclear Medicine Market by Applications
9.2.5.5 United Kingdom PET Nuclear Medicine Market
9.2.5.5.1 United Kingdom PET Nuclear Medicine Market by Type
9.2.5.5.2 United Kingdom PET Nuclear Medicine Market by Applications
9.2.5.6 Rest of Europe PET Nuclear Medicine Market
9.2.5.6.1 Rest of Europe PET Nuclear Medicine Market by Type
9.2.5.6.2 Rest of Europe PET Nuclear Medicine Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific PET Nuclear Medicine Market Overview
9.3.2 Asia-Pacific PET Nuclear Medicine Market Forecasts and Analysis
9.3.3 Asia-Pacific PET Nuclear Medicine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific PET Nuclear Medicine Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific PET Nuclear Medicine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia PET Nuclear Medicine Market
9.3.5.1.1 Australia PET Nuclear Medicine Market by Type
9.3.5.1.2 Australia PET Nuclear Medicine Market by Applications
9.3.5.2 China PET Nuclear Medicine Market
9.3.5.2.1 China PET Nuclear Medicine Market by Type
9.3.5.2.2 China PET Nuclear Medicine Market by Applications
9.3.5.3 India PET Nuclear Medicine Market
9.3.5.3.1 India PET Nuclear Medicine Market by Type
9.3.5.3.2 India PET Nuclear Medicine Market by Applications
9.3.5.4 Japan PET Nuclear Medicine Market
9.3.5.4.1 Japan PET Nuclear Medicine Market by Type
9.3.5.4.2 Japan PET Nuclear Medicine Market by Applications
9.3.5.5 South Korea PET Nuclear Medicine Market
9.3.5.5.1 South Korea PET Nuclear Medicine Market by Type
9.3.5.5.2 South Korea PET Nuclear Medicine Market by Applications
9.3.5.6 Rest of Asia-Pacific PET Nuclear Medicine Market
9.3.5.6.1 Rest of Asia-Pacific PET Nuclear Medicine Market by Type
9.3.5.6.2 Rest of Asia-Pacific PET Nuclear Medicine Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa PET Nuclear Medicine Market Overview
9.4.2 Middle East and Africa PET Nuclear Medicine Market Forecasts and Analysis
9.4.3 Middle East and Africa PET Nuclear Medicine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa PET Nuclear Medicine Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa PET Nuclear Medicine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa PET Nuclear Medicine Market
9.4.5.1.1 South Africa PET Nuclear Medicine Market by Type
9.4.5.1.2 South Africa PET Nuclear Medicine Market by Applications
9.4.5.2 Saudi Arabia PET Nuclear Medicine Market
9.4.5.2.1 Saudi Arabia PET Nuclear Medicine Market by Type
9.4.5.2.2 Saudi Arabia PET Nuclear Medicine Market by Applications
9.4.5.3 U.A.E PET Nuclear Medicine Market
9.4.5.3.1 U.A.E PET Nuclear Medicine Market by Type
9.4.5.3.2 U.A.E PET Nuclear Medicine Market by Applications
9.4.5.4 Rest of Middle East and Africa PET Nuclear Medicine Market
9.4.5.4.1 Rest of Middle East and Africa PET Nuclear Medicine Market by Type
9.4.5.4.2 Rest of Middle East and Africa PET Nuclear Medicine Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America PET Nuclear Medicine Market Overview
9.5.2 South and Central America PET Nuclear Medicine Market Forecasts and Analysis
9.5.3 South and Central America PET Nuclear Medicine Market Forecasts and Analysis - By Type
9.5.4 South and Central America PET Nuclear Medicine Market Forecasts and Analysis - By Applications
9.5.5 South and Central America PET Nuclear Medicine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil PET Nuclear Medicine Market
9.5.5.1.1 Brazil PET Nuclear Medicine Market by Type
9.5.5.1.2 Brazil PET Nuclear Medicine Market by Applications
9.5.5.2 Argentina PET Nuclear Medicine Market
9.5.5.2.1 Argentina PET Nuclear Medicine Market by Type
9.5.5.2.2 Argentina PET Nuclear Medicine Market by Applications
9.5.5.3 Rest of South and Central America PET Nuclear Medicine Market
9.5.5.3.1 Rest of South and Central America PET Nuclear Medicine Market by Type
9.5.5.3.2 Rest of South and Central America PET Nuclear Medicine Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PET NUCLEAR MEDICINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PET NUCLEAR MEDICINE MARKET, KEY COMPANY PROFILES
12.1. CARDINAL HEALTH
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CURIUM
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GE HEALTHCARE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. LANTHEUS MEDICAL IMAGING, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAYER AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BRACCO IMAGING S.P.A.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ECZACIBASI-MONROL NUCLEAR PRODUCTS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NORDION, INC. (A SUBSIDIARY OF STERIGENICS INTERNATIONAL)
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ADVANCED ACCELERATOR APPLICATIONS (AAA) (A PART OF NOVARTIS)
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NTP RADIOISOTOPES SOC, LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Cardinal Health
2. Curium
3. GE Healthcare
4. Lantheus Medical Imaging, Inc.
5. Bayer AG
6. Bracco Imaging S.P.A.
7. Eczacibasi-Monrol Nuclear Products
8. Nordion, Inc. (A Subsidiary of Sterigenics International)
9. Advanced Accelerator Applications (AAA) (A Part of Novartis)
10. NTP Radioisotopes Soc, LTD.
TIPRE00015978
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking